A detailed history of Simplex Trading, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 63,784 shares of SRPT stock, worth $7.96 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
63,784
Previous 66,780 4.49%
Holding current value
$7.96 Million
Previous $8.65 Million 16.56%
% of portfolio
0.34%
Previous 0.26%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$113.33 - $163.85 $339,536 - $490,894
-2,996 Reduced 4.49%
63,784 $10.1 Million
Q1 2024

Apr 25, 2024

BUY
$93.7 - $141.53 $3.24 Million - $4.89 Million
34,561 Added 107.27%
66,780 $8.65 Million
Q4 2023

Feb 02, 2024

BUY
$67.31 - $124.76 $582,904 - $1.08 Million
8,660 Added 36.76%
32,219 $3.11 Million
Q3 2023

Nov 01, 2023

SELL
$102.5 - $123.59 $1.26 Million - $1.52 Million
-12,276 Reduced 34.26%
23,559 $2.86 Million
Q2 2023

Aug 04, 2023

BUY
$106.4 - $157.19 $3.81 Million - $5.63 Million
35,835 New
35,835 $4.1 Million
Q1 2022

May 02, 2022

SELL
$63.15 - $90.42 $1.04 Million - $1.49 Million
-16,443 Closed
0 $0
Q4 2021

Feb 23, 2022

SELL
$77.28 - $99.42 $175,271 - $225,484
-2,268 Reduced 12.12%
16,443 $1.48 Million
Q3 2021

Oct 28, 2021

SELL
$65.97 - $92.48 $5,937 - $8,323
-90 Reduced 0.48%
18,711 $1.46 Million
Q2 2021

Aug 12, 2021

SELL
$69.38 - $86.75 $1.01 Million - $1.26 Million
-14,554 Reduced 43.63%
18,801 $1.46 Million
Q1 2021

Apr 26, 2021

BUY
$72.25 - $168.95 $2.41 Million - $5.64 Million
33,355 New
33,355 $0
Q4 2020

Feb 02, 2021

SELL
$125.56 - $178.74 $36,412 - $51,834
-290 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$127.12 - $172.34 $25,424 - $34,468
200 Added 222.22%
290 $40,000
Q1 2020

Apr 29, 2020

SELL
$82.38 - $131.64 $2.32 Million - $3.7 Million
-28,107 Reduced 99.68%
90 $8,000
Q4 2019

Feb 05, 2020

BUY
$76.53 - $135.58 $2.16 Million - $3.82 Million
28,197 New
28,197 $3.64 Million
Q3 2019

Oct 15, 2019

SELL
$72.81 - $156.91 $1.32 Million - $2.84 Million
-18,090 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$112.21 - $151.95 $1 Million - $1.35 Million
8,913 Added 97.12%
18,090 $2.75 Million
Q1 2019

Apr 18, 2019

BUY
$106.67 - $151.68 $319,689 - $454,584
2,997 Added 48.5%
9,177 $0
Q4 2018

Jan 16, 2019

SELL
$97.32 - $148.76 $380,034 - $580,907
-3,905 Reduced 38.72%
6,180 $674,000
Q3 2018

Oct 23, 2018

SELL
$115.31 - $161.51 $788,143 - $1.1 Million
-6,835 Reduced 40.4%
10,085 $1.63 Million
Q2 2018

Jul 30, 2018

SELL
$71.74 - $153.69 $32,928 - $70,543
-459 Reduced 2.64%
16,920 $2.24 Million
Q1 2018

Apr 26, 2018

SELL
$54.02 - $82.27 $44,296 - $67,461
-820 Reduced 4.51%
17,379 $1.29 Million
Q4 2017

Jan 10, 2018

SELL
$47.64 - $56.75 $1.34 Million - $1.6 Million
-28,197 Reduced 60.77%
18,199 $1.01 Million
Q3 2017

Oct 25, 2017

BUY
$35.73 - $47.15 $1.66 Million - $2.19 Million
46,396
46,396 $2.1 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.